Summary

  • Palmitoylethanolamide (PEA) is an endogenous fatty  acid amide analogue of the endocannabinoid anandamine, from the N-acylethanolamines family of lipid mediators
  • PEA Liquid is micronised to a 20um-25um particle size using laser diffraction
  • PEA is a clinically trialled ingredient
  • Presented in a coconut-derived (MCT) lipid suspension for ease of compounding
  • 2mL contains 300mg PEA for easy dose calculation
  • Synthesised from palmitic acid from sustainably sourced, RSPO certiied palm oil
  • PEA liquid contains 99% pure PEA, which has been conirmed by purity testing
  • Low allergen, clean formula
  • Pleasant natural orange lavour
  • Vegan friendly

Dosage & warnings

For extemporaneous compounding by a qualified health professional

Only take as directed.

Formulation

Ingredient
Palmitoylethanolamide (PEA) 300 mg